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LETTER TO THE EDITOR Open Access
ZEB2, a new candidate gene for asplenia
Linda Pons1, Sophie Dupuis-Girod1*, Marie-Pierre Cordier1, Patrick Edery1,2 and Massimiliano Rossi1,2
Abstract
Primary asplenia is a rare condition with poorly known etiology. Mowat-Wilson syndrome (MWS) is characterized by
typical facial dysmorphisms, intellectual disability, microcephaly, epilepsy and the possible presence of internal
organ malformations. It is caused by heterozygous mutations or deletions in the ZEB2 gene. Nearly 180 patients
have been reported to date, but only one with asplenia. We report here spleen hypo/aplasia in 4 out of 6 MWS
patients, with severe infectious complications for 3 of them. Our report shows that spleen hypo/aplasia is part of
the MWS phenotype and makes ZEB2 a possible candidate gene for primary asplenia.
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Letters to the editor
Primary congenital asplenia is a rare condition with poorly
known genetic bases. It can be part of multiple congenital
abnormalities syndromes or it can be isolated, which is ex-
tremely rare with about 70 patients reported to date [1].
Recently Bolze et al. identified heterozygous mutations in
the RPSA gene in more than half the patients studied with
isolated congenital asplenia [2]. Mowat-Wilson syndrome
(MWS, OMIM #235730) is characterized by typical facial
features (large medially sparse eyebrows, hypertelorism,
deep set eyes, uplifted ear lobes with central depression,
saddle nose and a pointed chin), intellectual disability,
microcephaly, epilepsy and congenital malformations in-
cluding Hirschsprung disease, genito-urinary abnormal-
ities, cardiac defects, corpus callosum agenesis and ocular
anomalies [3]. This syndrome was first described in 1998
[4] and is caused by heterozygous mutations or deletions
in the Zinc finger E-box-binding homeobox 2 gene
(ZEB2) [5,6]. Nearly 180 patients have been reported to
date. Asplenia was reported in only one case [7]. Interest-
ingly, it has been shown that ZEB2 has a diffuse expres-
sion in several mouse and human organs, including the
spleen [8,9].
We report here spleen hypo/aplasia in 4 out of 6 unre-
lated MWS patients referred to our genetic department,
with severe infectious complications for 3 of them.
The first patient is a female born to unrelated parents,
presenting with a typical facies, microcephaly, postnatal
short stature, developmental delay, corpus callosum agene-
sis, ventricular septal defect, strabismus and left dimmed vi-
sion. A de novo c.2083C >T heterozygous mutation of the
ZEB2 gene was identified, thus confirming the diagnosis.
At the age of 8 months, she suffered from purpura fulmi-
nans related to a severe Streptococcus Pneumoniae infection
(serotype 12 F) with severe necrosis sequellae including the
loss of 5 toes and the right heel requiring a skin graft.
Asplenia was diagnosed on ultrasound scan (USS).
The second patient is a female born to unrelated parents.
Typical dysmorphic features, microcephaly, developmental
delay, epilepsy, corpus callosum agenesis, ventricular septal
defect and patent ductus arteriosus, club foot and strabis-
mus were consistent with the diagnosis of MWS. A de novo
c.600_640dup heterozygous mutation of the ZEB2 gene
was identified. At the age of 1 year, she developed meningi-
tis related to Streptococcus Pneumoniae infection (serotype
17 F on cerebrospinal fluid culture) complicated by moder-
ate intracranial hypertension. USS revealed asplenia.
The third patient is a female born to unrelated parents.
She had typical facial dysmorphisms, severe intellectual dis-
ability, microcephaly, epilepsy, postnatal short stature, ven-
tricular septal defect, vesico-ureteric reflux, club foot and
unilateral choanal atresia. Molecular analysis of the ZEB2
gene showed a de novo c.1762G >T heterozygous mutation.
She had two pneumococcal septicemias at the ages of 2
and 3 years. Abdominal USS revealed severe splenic hypo-
plasia (main axis: 34 mm, average for weight: 80 mm, range
78–87 mm). Howell-Jolly bodies were absent.
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The fourth patient is a female born to non-related par-
ents, presenting with a typical facies, microcephaly, post-
natal short stature, developmental delay, epilepsy, atrial
septal defect and patent ductus arteriosus, strabismus. A
de novo c.2761C > T heterozygous mutation of the ZEB2
gene was identified confirming the diagnosis of MWS. She
had no severe infections. USS showed moderate splenic
hypoplasia (main axis: 46 mm, average for weight: 78 mm,
range 76–78 mm).
The 2 other MWS patients followed in our genetic de-
partment had a normal spleen on USS and did not have
severe infections.
On one hand, our report shows that spleen hypo/aplasia
is a part of the phenotype of MWS. USS should be system-
atically performed on MWS patients in order to rule out
spleen hypo/aplasia because of potential complications’ se-
verity. Prevention of severe infections in cases of asplenia
or severe hypoplasia, effectively requires appropriate anti-
biotic prophylaxis and vaccination that can restore the
pool of memory B cells [10].
As our cohort only includes 6 MWS subjects, we
think that other studies should be done to confirm if
asplenia/ spleen hypoplasia is a new feature of this mul-
tisystem disorder.
Indeed, the case of asplenia previously reported has a de
novo c.696C >G heterozygous mutation of ZEB2, so a dif-
ferent one from our patients. Furthermore, no spleen hypo/
aplasia has been described in previously reported patients
with de novo c.2083C >T or c.2761C >T heterozygous mu-
tations of ZEB2 found in patients 1 and 4 [11].
On the other hand, this report emphasizes the potential
role of ZEB2 in human spleen development. This associ-
ation makes this gene a possible new candidate for isolated
congenital asplenia. Indeed all cases cannot be attributed
to RPSA gene, suggesting a possible genetic heterogeneity.
Although mutations of ZEB2 are generally associated with
much more complex conditions, it cannot be excluded
that some missense mutations could be responsible for
apparently isolated asplenia [2].
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